Eastman Chemical (EMN) International Revenue Performance Explored
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
Presence in international markets can act as a hedge against domestic economic downturns and provide access to faster-growing economies. However, this diversification also brings complexities due to currency fluctuations, geopolitical risks and differing market dynamics.
Upon examining EMN's recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.
The company's total revenue for the quarter amounted to $2.29 billion, marking a decrease of 3.2% from the year-ago quarter. We will next turn our attention to dissecting EMN's international revenue to get a clearer picture of how significant its operations are outside its main base.
Trends in EMN's Revenue from International Markets
During the quarter, Asia Pacific contributed $583 million in revenue, making up 25.5% of the total revenue. When compared to the consensus estimate of $570.6 million, this meant a surprise of +2.17%. Looking back, Asia Pacific contributed $539 million, or 23.5%, in the previous quarter, and $590 million, or 25%, in the same quarter of the previous year.
Europe, Middle East, and Africa generated $610 million in revenues for the company in the last quarter, constituting 26.7% of the total. This represented a surprise of -1.08% compared to the $616.65 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe, Middle East, and Africa accounted for $610 million (26.6%), and in the year-ago quarter, it contributed $650 million (27.5%) to the total revenue.
Latin America accounted for 5.7% of the company's total revenue during the quarter, translating to $131 million. Revenues from this region represented a surprise of +4.35%, with Wall Street analysts collectively expecting $125.54 million. When compared to the preceding quarter and the same quarter in the previous year, Latin America contributed $121 million (5.3%) and $129 million (5.5%) to the total revenue, respectively.
International Revenue Predictions
Wall Street analysts expect Eastman Chemical to report a total revenue of $2.41 billion in the current fiscal quarter, which suggests a decline of 2.2% from the prior-year quarter. Revenue shares from Asia Pacific, Europe, Middle East, and Africa and Latin America are predicted to be 23.9%, 25.8%, and 5.5%, corresponding to amounts of $576.16 million, $621.44 million, and $132.27 million, respectively.
For the full year, the company is expected to generate $9.25 billion in total revenue, down 1.4% from the previous year. Revenues from Asia Pacific, Europe, Middle East, and Africa and Latin America are expected to constitute 24.6% ($2.28 billion), 26.5% ($2.45 billion) and 5.4% ($501.14 million) of the total, respectively.
Final Thoughts
Relying on international markets for revenues, Eastman Chemical faces both prospects and perils. Thus, tracking the company's international revenue trends is essential for accurately projecting its future trajectory.
In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.
We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.
Our proprietary stock rating tool, the Zacks Rank, with its externally validated exceptional track record, harnesses the power of earnings estimate revisions to serve as a dependable measure for anticipating the short-term price trends of stocks.
Currently, Eastman Chemical holds a Zacks Rank #4 (Sell), signifying its potential to underperform the overall market's performance in the forthcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Examining the Latest Trends in Eastman Chemical's Stock Value
Over the past month, the stock has lost 26.1% versus the Zacks S&P 500 composite's 0.6% increase. The Zacks Basic Materials sector, of which Eastman Chemical is a part, has declined 2.4% over the same period. The company's shares have declined 24.1% over the past three months compared to the S&P 500's 11.7% increase. Over the same period, the sector has risen 3.7%
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eastman Chemical Company (EMN) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition
On Tuesday, the eye care company Alcon Plc (NYSE:ALC) agreed to acquire STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the implantable collamer lens (ICL). The acquisition includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia (nearsightedness), with or without astigmatism. Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which represents approximately a 59% premium to STAAR's 90-day Volume Weighted Average Price (VWAP) and a 51% premium to the closing price of STAAR common stock on August 4, transaction represents a total equity value of approximately $1.5 billion. Alcon intends to finance the transaction by issuing short- and long-term credit facilities. The transaction is anticipated to close in approximately six to 12 months and is expected to be accretive to earnings in year two. 'With the number of high myopes rising globally, the acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK,' said David Endicott, CEO of Alcon. An estimated 50% of the world will be myopic by 2050, and today, nearly 500 million people are considered high myopes. The EVO family of ICLs are implanted between the iris (the colored part of the eye) and the natural crystalline lens during a procedure that does not remove corneal tissue. This move follows Alcon's recent announcement in July regarding its intention to acquire LumiThera, Inc. and its Photobiomodulation (PBM) Device for dry age-related macular degeneration (AMD). Data from the LIGHTSITE I, II, and III clinical trials consistently showed that PBM treatments provide visual acuity improvement with no treatment-related serious adverse events reported. PBM received FDA de novo market authorization in November 2024 and CE Mark in November 2018. PBM is available in Europe, Latin America, Singapore, the U.K., and the U.S. The transaction does not include the acquisition of AdaptDx and Nova/Diopsys diagnostic devices, which will be separated and spun off to LumiThera's shareholders before Alcon's acquisition and will continue to be marketed and sold by the LumiThera spin-off. Alcon and LumiThera anticipate the acquisition to be completed in the third quarter of 2025. Price Action: ALC stock is trading lower by 1.17% to $86.79 premarket, and STAA stock is trading higher by 44.9% to $26.78 at last check Tuesday. Read Next:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? STAAR SURGICAL (STAA): Free Stock Analysis Report This article Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
3 Things to Know Before Investing in Stablecoins
Key Points If the goal is to maximize wealth, investors might want to consider putting their money into stablecoin issuers, rather than stablecoins. Stablecoins are not risk-free investments. In addition to the two stablecoin giants (Tether, USDC), dozens of other stablecoins can be used for a wide range of purposes. 10 stocks we like better than USDC › While stablecoins have been around for more than a decade, it's only recently that they have really burst into the spotlight. The stablecoin industry is now valued at $250 billion, and could be on its way to $2 trillion within just a few years. In fact, according to the latest Motley Fool stablecoin research, 10 different stablecoins now have market caps of $450 million or more. So investors have plenty of choices. Here's what you need to know before getting started. You won't get rich investing in stablecoins This might be obvious, but the price of a stablecoin will always be $1. It doesn't matter how popular the stablecoin becomes, how many people use it, or how many business use cases there are for it. Your stablecoin will always be worth $1. Even if you buy and hold that stablecoin for decades, it will still be worth just $1 at the end of that period. And that's the way it was meant to be. It's a feature, not a flaw. Stablecoins were created to eliminate some of the risk and volatility of investing in crypto. Since stablecoins are pegged 1:1 to the dollar, you can always swap one stablecoin for $1. This makes it very easy to move money between the worlds of traditional finance and blockchain finance. It also ensures that you can use stablecoins for transactions, due to the price stability. But all hope is not lost if you want to make money with stablecoins. You could, for example, invest in the issuers of the stablecoins. For example, consider the difference between investing in USDC (CRYPTO: USDC), the world's second-most-popular stablecoin, and investing in Circle Internet Group (NYSE: CRCL), the issuer of USDC. Since it went public on June 5, the price of Circle has soared by nearly 130%. However, the price of USDC is still just $1. You might get rich investing in Circle, but you definitely won't get rich investing in USDC. Stablecoins are not risk-free investments Judging by their name, you might assume that stablecoins are risk-free investments. What could possibly go wrong with such a "stable" investment? As it turns out, a lot. The most glaring risk is the potential for a stablecoin to lose its peg to the U.S. dollar. In other words, instead of being able to exchange your stablecoin for $1, you might get significantly less. And, if a market meltdown occurs, you might get nothing. This actually happened in 2022, when the stablecoin TerraUSD dramatically lost its peg to the dollar. Within a span of 24 hours, it was trading for mere pennies. Thus, it's essential to understand how an issuer is choosing to back its stablecoin. The two biggest stablecoins -- Tether (CRYPTO: USDT) and USDC -- are backed entirely by cash and high-quality cash equivalents. However, prior to the passage of the Genius Act this summer, other issuers were using a mix of just about everything -- including volatile cryptocurrencies, low-grade commercial paper, and gold -- to back their stablecoins. Not all stablecoins are created equal At first glance, it might seem like all stablecoins are the same. After all, they all trade for $1, right? But that's hardly the case. For example, some stablecoins are optimized for cross-border transactions. Some stablecoins are designed to maximize yield via various decentralized finance (DeFi) protocols. Some stablecoins provide liquidity to help crypto traders move quickly between various cryptocurrencies and across different blockchains. And some stablecoins are pegged to a different fiat currency other than the dollar, such as the yen or euro. Thus, the choice of which stablecoin is best for you depends on how you plan to use it. If you live in Paris or Tokyo, a dollar-pegged stablecoin might not make sense for you. That being said, you really can't go wrong investing in either of the two stablecoin behemoths (Tether, USDC). You can use those stablecoins for just about anything, and they're highly liquid. Now that the Genius Act has passed, I'm fully expecting a new range of use cases to emerge. For example, based on previous media reports from the likes of the Wall Street Journal and Fortune, the names of companies considering stablecoin launches of their own include Amazon (NASDAQ: AMZN), Walmart (NYSE: WMT), Uber (NYSE: UBER), X, Airbnb (NASDAQ: ABNB), and Meta Platforms (NASDAQ: META). It's hard to believe that all of them will create cookie-cutter stablecoins. Instead, they'll create stablecoins that are optimized for how they do business. So, as they say, always read the fine print when you choose to invest in stablecoins. A little due diligence upfront could save you a lot of headaches further down the road. Do the experts think USDC is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did USDC make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,039% vs. just 181% for the S&P — that is beating the market by 858.19%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Dominic Basulto has positions in Amazon, Circle Internet Group, and USDC. The Motley Fool has positions in and recommends Airbnb, Amazon, Meta Platforms, Uber Technologies, and Walmart. The Motley Fool has a disclosure policy. 3 Things to Know Before Investing in Stablecoins was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
Caterpillar tariff warning, Yum misses, Marriott cuts outlook
Yahoo Finance Senior Reporter Brooke DiPalma joins Morning Brief with Julie Hyman to share the latest on earnings for Caterpillar (CAT), Yum Brands (YUM), and Marriott (MAR). To watch more expert insights and analysis on the latest market action, check out more Morning Brief. Caterpillar, Brooke, that is talking about, uh, tariff effect on its business. Yeah, AI and everything else here. When you think about Caterpillar, of course, that yellow and black iconic behind the bulldozers, behind construction, you see that stock under pressure in early hours, extended hours here this morning. And what we heard in the presentation that Caterpillar put on their investor website is that tariffs are expected to net incremental tariffs are around 1.3 billion to 1.5 billion. That's expected to hit the company this year. They said that that includes as much as 500 million this upcoming quarter alone. And this is a stock that has been under pressure as we continue to make way into the year as we try to understand what exactly these tariffs mean for these manufacturing companies. The company also did say that those tariffs, they drove up manufacturing costs for the company. That hit profit even as sales volumes remained steady. So it's clearly we're seeing some of the tariff impact show up for these companies. And now keep in mind after that extended deadline, the CEO saying on the call this morning that this is expected to now hit the company come August 7th when that deadline shows up. And, and then, Brooke, also on the earnings front, I know you're watching everything consumer, as you do, uh, what are we hearing on that front in terms of earnings this morning? Yeah, internationally, the consumer does well, but here in the US we're seeing a softening and that was reiterated this morning with both Yum Brands as well as Marriott. This international growth offsetting a slowdown here in the US. And taking a closer look at the US same-store sales growth for Yum Brands, what we saw was an ongoing continuation of Taco Bell really outperforming its peers, KFC and Pizza Hut. What we saw there was Taco Bell was the only sore, uh, only segment of the Yum Brands, uh, business that saw same-store sales up. And then we saw a decline of 5% from both Pizza Hut, as well as KFC here in the US, especially as they really try to drum up excitement. We know that KFC is falling behind the competition when it comes to the chicken business, when it comes to, you know, up and coming competitors as well, like Dave's Hot Chicken among others. And what we saw is in from Marriott International, that they actually cut their full year forecast for revenue growth and profit. They cited a slowdown in demand for travel here in the US, but once again international, they did say that that offset some of the slowdown that we're seeing here.